Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

Last updated: May 15, 2025
Sponsor: Next Biomedical Co., Ltd.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteoarthritis

Treatment

embolization therapy

Clinical Study ID

NCT06930677
TAME-003
  • Ages > 50
  • All Genders

Study Summary

Study in patients with knee osteoarthritis treated by embolization using NBGM200

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Osteoarthritis proven by MR-imaging

Exclusion

Exclusion Criteria:

  • Current local infection

  • Life expectancy less than 6 months

Study Design

Total Participants: 72
Treatment Group(s): 1
Primary Treatment: embolization therapy
Phase:
Study Start date:
April 17, 2025
Estimated Completion Date:
February 28, 2027

Connect with a study center

  • University Hospital Ghent

    Ghent,
    Belgium

    Site Not Available

  • Uz Leuven

    Leuven,
    Belgium

    Site Not Available

  • Elisabeth-Tweesteden Hospital

    Tilburg,
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.